본문 바로가기

business

Research study and Product Resources

Research study and Product Resources 목록
Title Data
NK VUE ELISA Insert (CE) 논문
NK VUE Tube Insert (CE) 논문
[NK Vue] Cross-Sectional and Time-Dependent Analyses on Inflammatory Markers following Natural Killer Cell Activity. (Diagnostics. 2022) 관련사이트
[NK Vue] Prognostic value of natural killer cell activity for patients with HER2+ advanced gastric cancer treated with first-line fluoropyrimidine-platinum doublet plus trastuzumab. (Cancer Immunol Immunother. 2021) 관련사이트
[NK Vue] Changes in natural killer cell activity after surgery and predictors of its recovery-failure. (J Surg Oncol. 2021) 관련사이트
[SuperNK] A Phase I/IIa Randomized Trial Evaluating the Safety and Efficacy of SNK01 Plus Pembrolizumab in Patients with Stage IV Non-Small Cell Lung Cancer 관련사이트
Delayed NK Cell Reconstitution and Reduced NK Activity Increased the Risks of CMV Disease in Allogeneic-Hematopoietic Stem Cell Transplantation. (Int J Mol Sci. 2020) 관련사이트
Lower postoperative natural killer cell activity is associated with positive surgical margins after radical prostatectomy. (J Formos Med Assoc. 2020) 관련사이트
Impact of Smoking on Human Natural Killer Cell Activity: A Large Cohort Study. (J Cancer Prev. 2020) 관련사이트
Natural Killer Cells as a Potential Biomarker for Predicting Immunotherapy Efficacy in Patients with Non Small Cell Lung Cancer. (Target Oncol. 2020) 관련사이트
Natural Killer Cell Function Tests by Flowcytometry-Based Cytotoxicity and IFN-γ Production for the Diagnosis of Adult Hemophagocytic Lymphohistiocytosis. (Int J Mol Sci. 2019) 관련사이트
Natural killer cell activity and prostate cancer risk in veteran men undergoing prostate biopsy. (Cancer Epidemiol. 2019) 관련사이트
Correlation Between Natural Killer Cell Activity and Treatment Effect in Patients with Disseminated Cancer. (Transl Oncol. 2019) 관련사이트
Clinical utility of a novel natural killer cell activity assay for diagnosing non-small cell lung cancer: a prospective pilot study. (Onco Targets Ther. 2019) 관련사이트
Relationship between natural killer cell activity and glucose control in patients with type 2 diabetes and prediabetes. (J Diabetes Investig. 2019) 관련사이트

Move to Top